Eire, you recently posted that the HPV RNA oncology program is actually underway.
Presumably a pre-clinical mouse study such as has already happened with HPV Head&Neck?
Also, any thoughts as to why we have not heard any more about who the big pharma partner is and what the terms are? (WP, 28/2/17, said we would hear "very soon").
Perhaps there are things afoot other than just this one program? .....
Would value your thoughts.
Eire, you recently posted that the HPV RNA oncology program is...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.00 |
Change
0.000(0.00%) |
Mkt cap ! $253.6M | |||
| Open | High | Low | Value | Volume |
| $11.88 | $12.00 | $11.50 | $261.8K | 22.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 156 | $11.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.00 | 6045 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |